Internal Medicine, Infectious Disease · Concord, NC
NPI
1588872642
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
200 Medical Park Dr, Ste 280
Concord, NC, 28025
Phone (704) 403-1766
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
565 services
Medicare patients, 2024
210
Average age 72
Drug cost, 2024
$918K
636 prescriptions
Company payments, 2025
$14.96
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tedra M Claytor was code 99232 (hospital e&m - subsequent), 295 times for 138 patients. In total Tedra M Claytor billed 565 services in 12 codes, and Medicare paid $40K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 295 | 138 | $56.72 | $17K |
| 99222 Hospital E&M - Initial | Facility | 153 | 143 | $90.57 | $14K |
| 99214 Office E&M - Established | Office | 48 | 34 | $87.61 | $4,205 |
| 99232 Hospital E&M - Subsequent | Office | 15 | 12 | $53.71 | $806 |
| 99231 Hospital E&M - Subsequent | Facility | 12 | 12 | $36.03 | $432 |
By year: 2022 $48K for 669 services; 2023 $43K for 551 services; 2024 $40K for 565 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tedra M Claytor prescribed most often to Medicare patients was Genvoya (Elviteg/Cob/Emtri/Tenof Alafen), with 37 prescriptions and refills. In total Tedra M Claytor wrote 636 Medicare prescriptions that cost $918K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 37 | 37 | Under 11 | $152K |
| Azithromycin Generic | 33 | 50 | Under 11 | $1,570 |
| Valacyclovir Valacyclovir Hcl | 32 | 38 | Under 11 | $829 |
| Doxycycline Hyclate Generic | 32 | 36 | 18 | $261 |
| Ethambutol Hcl Generic | 30 | 48 | Under 11 | $2,025 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 27 | 32 | 21 | $571 |
| Cephalexin Generic | 27 | 35 | Under 11 | $393 |
| Dovato Dolutegravir Sodium/Lamivudine | 25 | 25 | Under 11 | $73K |
| Cefadroxil Generic | 23 | 39 | 12 | $898 |
| Fluconazole Generic | 23 | 38 | Under 11 | $1,051 |
| Levofloxacin Generic | 22 | 22 | Under 11 | $195 |
| Ertapenem Ertapenem Sodium | 19 | 19 | Under 11 | $11K |
| Ceftriaxone Ceftriaxone Sodium | 19 | 19 | Under 11 | $1,754 |
| Minocycline Hcl Generic | 18 | 32 | 12 | $617 |
| Tivicay Dolutegravir Sodium | 17 | 25 | Under 11 | $54K |
Brand drugs: 163 claims; generic drugs: 473 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tedra M Claytor $14.96 ($14.96 in general payments such as food, travel and fees) from 1 company. The largest payer was Paratek Pharmaceuticals, Inc. with $14.96.
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 1 | $14.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.